Vertex Pharmaceuticals (VRTX) EBIT (2009 - 2026)
Vertex Pharmaceuticals' quarterly EBIT came in at $1.1 billion in Q1 2026, up 80.62% year-on-year from $630.1 million in Q1 2025, and down 5.62% quarter-over-quarter from $1.2 billion in Q4 2025.
Vertex Pharmaceuticals has reported EBIT for 18 years, with the latest figure at $1.1 billion in Q1 2026.
- For the quarter ending Q1 2026, EBIT rose 80.62% year-over-year to $1.1 billion; the trailing twelve-month figure through Mar 2026 stood at $4.7 billion (up 730.65% YoY), and the FY2025 full-year result was $4.2 billion, up 1891.88% from the prior year.
- EBIT for Q1 2026 stood at $1.1 billion, down from $1.2 billion in the prior quarter.
- The five-year high for EBIT was $1.2 billion in Q4 2025, with the low at -$3.5 billion in Q2 2024.
- Average EBIT over 5 years is $777.5 million, with a median of $1.0 billion recorded in 2022.
- Year-over-year, EBIT surged 3019.0% in 2022 and slumped 442.43% in 2024.
- Tracing VRTX's EBIT over 5 years: stood at $1.0 billion in 2022, then fell by 4.35% to $988.5 million in 2023, then gained by 3.79% to $1.0 billion in 2024, then increased by 17.53% to $1.2 billion in 2025, then declined by 5.62% to $1.1 billion in 2026.
- The last three EBIT figures came in at $1.1 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - | -445.22 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.14 Bn |
| Dec 31, 2025 | 1.21 Bn |
| Sep 30, 2025 | 1.19 Bn |
| Jun 30, 2025 | 1.15 Bn |
| Mar 31, 2025 | 630.10 Mn |
| Dec 31, 2024 | 1.03 Bn |
| Sep 30, 2024 | 1.12 Bn |
| Jun 30, 2024 | -3.51 Bn |
| Mar 31, 2024 | 1.14 Bn |
| Dec 31, 2023 | 988.50 Mn |
| Sep 30, 2023 | 1.04 Bn |
| Jun 30, 2023 | 1.03 Bn |
| Mar 31, 2023 | 779.00 Mn |
| Dec 31, 2022 | 1.03 Bn |
| Sep 30, 2022 | 1.13 Bn |
| Jun 30, 2022 | 1.11 Bn |
| Mar 31, 2022 | 1.04 Bn |
| Dec 31, 2021 | 877.70 Mn |
| Sep 30, 2021 | 1.05 Bn |
| Jun 30, 2021 | -37.90 Mn |
| Mar 31, 2021 | 887.80 Mn |
| Dec 31, 2020 | 745.79 Mn |
| Sep 30, 2020 | 672.24 Mn |
| Jun 30, 2020 | 718.03 Mn |
| Mar 31, 2020 | 720.22 Mn |
| Dec 31, 2019 | 551.47 Mn |
| Sep 30, 2019 | 99.33 Mn |
| Jun 30, 2019 | 269.96 Mn |
| Mar 31, 2019 | 276.81 Mn |
| Dec 31, 2018 | 127.72 Mn |
| Sep 30, 2018 | 205.65 Mn |
| Jun 30, 2018 | 172.88 Mn |
| Mar 31, 2018 | 128.90 Mn |
| Dec 31, 2017 | 125.74 Mn |
| Sep 30, 2017 | -326.04 Mn |
| Jun 30, 2017 | 52.71 Mn |
| Mar 31, 2017 | 270.84 Mn |
| Dec 31, 2016 | 39.64 Mn |
| Sep 30, 2016 | -18.73 Mn |
| Jun 30, 2016 | 3.35 Mn |
| Mar 31, 2016 | -14.33 Mn |
| Dec 31, 2015 | -53.70 Mn |
| Sep 30, 2015 | -70.03 Mn |
| Jun 30, 2015 | -171.16 Mn |
| Mar 31, 2015 | -171.99 Mn |
| Dec 31, 2014 | -153.63 Mn |
| Sep 30, 2014 | -142.20 Mn |
| Jun 30, 2014 | -180.54 Mn |
| Mar 31, 2014 | -216.04 Mn |
| Dec 31, 2013 | -10.28 Mn |
| Sep 30, 2013 | -123.56 Mn |
| Jun 30, 2013 | -47.03 Mn |
| Mar 31, 2013 | -429.14 Mn |
| Dec 31, 2012 | -77.48 Mn |
| Sep 30, 2012 | -1.07 Mn |
| Jun 30, 2012 | -10.77 Mn |
| Mar 31, 2012 | 91.65 Mn |
| Dec 31, 2011 | 223.90 Mn |
| Sep 30, 2011 | 215.71 Mn |
| Mar 31, 2011 | -159.90 Mn |
| Dec 31, 2010 | -166.63 Mn |
| Sep 30, 2010 | -199.59 Mn |
| Jun 30, 2010 | -169.57 Mn |
| Mar 31, 2010 | -160.28 Mn |
| Dec 31, 2009 | -146.72 Mn |
| Sep 30, 2009 | -148.23 Mn |
| Jun 30, 2009 | -157.17 Mn |
| Mar 31, 2009 | -161.89 Mn |